EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Macroprolactin over time: Is there any point in rechecking it in people with a persistently elevated serum prolactin?

Mark Livingston, Syeda F Hashmi, Sudarshan Ramachandran, Ian Laing, Adrian Heald iD

Clinical Endocrinology · 2024

DOI: 10.1111/cen.15051 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Endocrinology, 2024. Verfasst von Mark Livingston und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Biochemistry, Black Country Pathology Services , Walsall Manor Hospital, Walsall, UK. Hauptthemen laut MEDLINE: Hyperprolactinemia, Prolactinoma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective and Design Macroprolactinemia may influence the interpretation of serum prolactin levels—a recognised phenomenon since 1981. The degree of macroprolactinaemia over time is less well described. We determined how macroprolactin status (based on polyethylene glycol (PEG) precipitation) varied by analysing serial measurements in hyperprolactinaemic individuals over a period of 9 years. Patients and Measurements Results from 1810 individuals were included. All serum total prolactin results (measured using Roche Cobas 8000 analyser) were extracted from the laboratory information system for the period 1 January 2012 to 1 April 2021, along with relevant patient demographic/test data. Samples with a macroprolactin screening test performed (on samples with prolactin > 700 miu/L) were included in the main analysis. Results During the study period, 2782 macroprolactin checks were performed (12.5% of all prolactin tests) in 1810 individuals (599 males/2183 females, median‐age: 35, interquartile range: 25–47, range: 16–93 years). Multiple macroprolactin checks were carried out on 465 patients (1437 measurements) with 94 patients (141 measurements) screening positive (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyperprolactinemiaProlactinomaAdultFemaleHumansMaleProlactin

Stichwörter der Autor:innen

longitudinal trendmacroprolactinmonitoringprolactin

Substanzen

Prolactinprolactin, polymeric

Autor:innen und Institutionen

  • Department of Clinical Biochemistry, Black Country Pathology Services , Walsall Manor Hospital, Walsall, UK.
  • Faculty of Science and Engineering, School of Medicine and Clinical Practice, The University of Wolverhampton, Wolverhampton, UK.
  • Department of Clinical Biochemistry, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
  • Department of Clinical Biochemistry, University Hospitals of North Midlands, Stoke-on-Trent, UK.
  • Institute of Science and Technology, Keele University, Keele, UK.
  • Faculty of Health Sciences, Staffordshire University, Stoke-on-Trent, UK.

ORCID-Profile: Adrian Heald

Zitieren

APA

Livingston, M., Hashmi, S. F., Ramachandran, S., Laing, I., & Heald, A. (2024). Macroprolactin over time: Is there any point in rechecking it in people with a persistently elevated serum prolactin?. Clinical Endocrinology. https://doi.org/10.1111/cen.15051

Vancouver

Livingston M, Hashmi SF, Ramachandran S, Laing I, Heald A. Macroprolactin over time: Is there any point in rechecking it in people with a persistently elevated serum prolactin?. Clinical Endocrinology. 2024. doi:10.1111/cen.15051

BibTeX
@article{Livingston2024,
  author = {Livingston, Mark and Hashmi, Syeda F and Ramachandran, Sudarshan and Laing, Ian and Heald, Adrian},
  title = {Macroprolactin over time: Is there any point in rechecking it in people with a persistently elevated serum prolactin?},
  journal = {Clinical Endocrinology},
  year = {2024},
  doi = {10.1111/cen.15051}
}
Kostenlos starten →